SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012957
Filing Date
2018-05-10
Accepted
2018-05-10 16:16:23
Documents
64
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-10q_20180331.htm 10-Q 1012603
2 EX-31.1 clsd-ex311_6.htm EX-31.1 16692
3 EX-31.2 clsd-ex312_12.htm EX-31.2 16689
4 EX-32.1 clsd-ex321_7.htm EX-32.1 9008
  Complete submission text file 0001564590-18-012957.txt   4459460

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clsd-20180331.xml EX-101.INS 980692
6 XBRL TAXONOMY EXTENSION SCHEMA clsd-20180331.xsd EX-101.SCH 41160
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20180331_cal.xml EX-101.CAL 46324
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20180331_def.xml EX-101.DEF 101299
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20180331_lab.xml EX-101.LAB 292230
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20180331_pre.xml EX-101.PRE 218229
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 18822725
SIC: 2834 Pharmaceutical Preparations